Wells Fargo Downgrades Kymera Therapeutics (KYMR) to Equal Weight, 'Lack of Catalysts in 2024'
Go back to Wells Fargo Downgrades Kymera Therapeutics (KYMR) to Equal Weight, 'Lack of Catalysts in 2024'| (NASDAQ: KYMR) | Delayed: 121.10 -0.31 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $121.41 | 52 Week High | $ | |||
| Open | $119.75 | 52 Week Low | $ | |||
| Day High | $121.23 | P/E | N/A | |||
| Day Low | $118.09 | EPS | $ | |||
| Volume | 274,794 | |||||

